ArticleThe Eurasian journal of medicine2026
High Prevalence of Non-thyroidal Illness Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our aim was to estimate the prevalence of non-thyroidal illness syndrome in individuals with chronic obstructive pulmonary disease (COPD). A systematic review and meta-analysis of studies indexed in Embase, ScienceDirect, PubMed, Virtual Health Library, Web of Science, and Cochrane Library from inception through December 31, 2023, was performed. The protocol was registered in PROSPERO (CRD42024492108). Pooled prevalence and 95% CIs were calculated using the DerSimonian-Laird random-effects model, and heterogeneity was assessed with the I2 statistic. Meta-regression analyses examined the influence of age, sex, and smoking status. Subgroup and sensitivity analyses were performed, and associations with arterial blood gas parameters (PaO₂, PaCO₂, and SaO₂) were evaluated using the inverse-variance method within a random-effects framework. Eleven studies including 1005 chronic obstructive pulmonary disease patients met the inclusion criteria. The overall pooled prevalence of non-thyroidal illness syndrome was 44.2% (95% CI, 30.0-58.4%) with high heterogeneity (I2, 96.1%). Non-thyroidal illness syndrome was more common during acute exacerbations (54.5%) than in stable disease (13.8%). Meta-regression analyses showed that age, sex, and smoking status did not significantly account for heterogeneity. Among arterial blood gas parameters, a modest but statistically significant reduction in SaO₂ was observed in patients with non-thyroidal illness syndrome compared with those without (-2.65%, 95% CI, -4.56 to -0.74). No significant differences were detected for PaO₂ or PaCO₂. As a conclusion, non-thyroidal illness syndrome is a common finding in patients with COPD, particularly during acute exacerbations, and is associated with reduced oxygen saturation. These findings highlight the importance of monitoring thyroid function and oxygenation in this population. Cite this article as: Vázquez PF, Diez-Manglano J. High prevalence of non-thyroidal illness syndrome in patients with chronic obstructive pulmonary disease: A systematic review and metaanalysis. Eurasian J Med. 2026, 58(3), 1290, doi: 10.5152/eurasianjmed.2026.251290.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.